Molecular testing in the diagnosis of differentiated thyroid carcinomas

about

Molecular testing in the diagnosis of differentiated thyroid carcinomas

Item

http://www.wikidata.org/entity/Q58805430

description

scientific article published on 01 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Molecular testing in the diagnosis of differentiated thyroid carcinomas

@en

Molecular testing in the diagnosis of differentiated thyroid carcinomas

@nl

type

Item

label

Molecular testing in the diagnosis of differentiated thyroid carcinomas

@en

Molecular testing in the diagnosis of differentiated thyroid carcinomas

@nl

prefLabel

Molecular testing in the diagnosis of differentiated thyroid carcinomas

@en

Molecular testing in the diagnosis of differentiated thyroid carcinomas

@nl

P1476

Molecular testing in the diagnosis of differentiated thyroid carcinomas

@en

P2093

Alessandro Antonelli

http://www.w3.org/2001/XMLSchema#string

Enke Baldini

http://www.w3.org/2001/XMLSchema#string

Francesca Ragusa

http://www.w3.org/2001/XMLSchema#string

Fulvio Basolo

http://www.w3.org/2001/XMLSchema#string

Giusy Elia

http://www.w3.org/2001/XMLSchema#string

Ilaria Ruffilli

http://www.w3.org/2001/XMLSchema#string

Paolo Miccoli

http://www.w3.org/2001/XMLSchema#string

Poupak Fallahi

http://www.w3.org/2001/XMLSchema#string

Sabrina Rosaria Paparo

http://www.w3.org/2001/XMLSchema#string

Silvia Martina Ferrari

http://www.w3.org/2001/XMLSchema#string

P2860

Angiogenesis-inhibitors for metastatic thyroid cancer

TERT promoter mutations in thyroid cancer

RAS mutations in thyroid cancer

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

Cancer statistics, 2013

Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study

Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

Cancer statistics, 2009

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

P304

S19-S29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/GS.2017.11.07

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Riccardo Giannini

Salvatore Ulisse

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30175060

http://www.w3.org/2001/XMLSchema#string

P921

diagnosis

P932

6107603

http://www.w3.org/2001/XMLSchema#string